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Obesity is linked to chronic inflammation in white adipose tissue (WAT) which is 
exacerbated by infiltrating macrophages (M)s.  Grape powder extract (GPE) contains 
polyphenols that have the potential to prevent this inflammatory response that can 
otherwise lead to insulin resistance.  Therefore, this research examined the extent to 
which GPE prevents lipopolysaccharide (LPS)-induced inflammatory response in human 
Ms.  Pretreatment of human Ms with GPE prevented LPS-mediated activation of 
mitogen activated protein kinases (MAPK)s, nuclear factor kappa B (NFκB), and 
activator protein (AP)-1, and induction of inflammatory genes.  Furthermore, GPE 
decreased the capacity of LPS-stimulated Ms to inflame adipocytes and cause insulin 
resistance.  My preliminary data show that in the absence of LPS, quercetin (QUE), a 
polyphenol abundantly found in GPE, attenuated inflammatory gene expression, c-Jun N-
terminal kinase (JNK) and c-Jun activation, and IκBα degradation in human Ms.   In 
addition, QUE pretreatment of Ms prevented insulin resistance in human adipocytes 
exposed to M-CM.  Taken together, these data show that polyphenol-rich GPE 
decreases inflammation in human Ms and M-mediated insulin resistance in human 
adipocytes.  Lastly, these data suggest that QUE may be one of the polyphenols in GPE 
that decrease inflammation and insulin resistance in human MФs and adipocytes.
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CHAPTER I 
 
INTRODUCTION 
 
 
This thesis is part of an ongoing project whose long term goal is to identify 
potential health benefits of a polyphenol-rich grape powder extract (GPE).  These studies 
are expected to identify dietary strategies for controlling chronic inflammation and 
insulin resistance associated with obesity.  The incidence of obesity is increasing 
worldwide and due to its associated comorbidities, is becoming a major public health 
concern (reviewed in Tilg et al. 2006 and Poirier et al. 2006).  Obesity is associated with 
a low-grade, chronic inflammatory disease characterized by macrophage (MΦ) 
infiltration into white adipose tissue (WAT) (reviewed in Cottam et al. 2004 and 
Trayhurn et al. 2004).  Secretion of proinflammatory mediators from activated MΦs 
exacerbates WAT inflammation, thereby contributing to the pathogenesis of obesity-
related diseases such as atherosclerosis, type 2 diabetes, and hypertension (Laine et al. 
2007) (Fig. 1.1).  Therefore, preventing MΦ inflammation with bioactive components in 
grapes could help prevent or attenuate the severity of these obesity-related diseases. 
Overview 
Grapes are one of the most widely consumed fruits in the world (Sakurai et al. 
2009).  They contain a variety of polyphenols such as quercetin (QUE) that have anti-
oxidant and anti-inflammatory properties.  For example, QUE (Stewart et al. 2008, 
Rivera et al. 2008) has been shown to reduce inflammation and insulin resistance in
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rodent models. However, the specific bioactive component(s) in GPE and the 
mechanism(s) by which they prevent inflammation or improve insulin sensitivity are still 
unclear. 
 The central hypothesis tested in this thesis was that GPE will prevent inflammation in 
human MΦs by blocking the activation of mitogen activated protein kinases (MAPK)s, 
activator protein (AP)-1, and nuclear factor kappa B (NFκB) (Fig 1.2). Cross-talk 
between MΦs and adipocytes was also examined, because MΦs have been reported to 
cause inflammation and insulin resistance in adipocytes.  The specific aim of this study 
was to determine the extent to which GPE prevents inflammation in human MΦs.  The 
working hypothesis for this aim was that GPE will block lipopolysaccharide (LPS)-
mediated activation of MAPKs [i.e., c-Jun N-terminal kinase (JNK), p38], NFκB, or AP-
1 that increase the transcription of inflammatory genes in human MΦs.  In addition, GPE 
will decrease the capacity of LPS-stimulated MΦs to inflame adipocytes and cause 
insulin resistance.   
Central Hypothesis and Specific Aim 
 The expected outcomes of this specific aim were that GPE will decrease markers 
of inflammation (i.e., gene expression, protein secretion) in MΦs by blocking LPS-
mediated activation of JNK, p38, NFκB, or AP-1 (i.e. c-Jun).  Furthermore, GPE will 
decrease the capacity of LPS-stimulated MΦs to inflame adipocytes and cause insulin 
resistance.  Collectively, these outcomes are expected to promote the development of 
novel dietary strategies to prevent or attenuate obesity-associated inflammation.  
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 Obesity-related inflammation and chronic disease are the most prevalent nutrition-
related health problems in the U.S. (Anon 2007).  Obesity-associated inflammation is 
characterized by an increased abundance of MΦs in WAT, leading to the production of 
inflammatory cytokines, chemokines, and prostaglandin (PG)s that can cause insulin 
resistance.  What is needed is a naturally-occurring food or dietary component without 
side effects that prevents chronic inflammation or insulin resistance.  Grapes are one of 
the most widely consumed fruits in the world and they contain high concentrations of 
polyphenols which have been shown in vivo and in vitro to exert anti-inflammatory and 
anti-oxidant actions (Sakurai et al. 2009).  However, the ability of GPE and its 
polyphenols to prevent inflammation in human MΦs and block inflammation or cross-
talk with human adipocytes and their mechanism of action are unknown.  As an outcome 
of the proposed investigations, I expect to have determined a mechanism by which GPE 
attenuates inflammation in human MΦs.  This will result in decreased inflammation and 
insulin resistance in adipocytes.   The research proposed is significant, because it could 
potentially lead to improvements in the nation’s health and nutrition and reduce health 
care costs.   
Background and Significance 
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 Metabolic endotoxemia (i.e., high plasma levels of LPS) is associated with obesity 
(Cani et al. 2008), which contributes to inflammation and insulin resistance. LPS 
activates MAPKs, NFκB, and AP-1, increasing the release of inflammatory cytokines and 
chemokines (Terra et al. 2007, Jang et al. 2008, Chen et al. 2007). In obesity, the 
increased production of these inflammatory mediators originates mainly from infiltrating 
MΦs in WAT (Xu et al. 2003, Weisberg et al. 2003). MΦ-secreted factors have been 
shown to increase inflammation and decrease insulin-stimulated glucose uptake in 
adipocytes (Lumeng et al. 2007, Permana et al. 2006).  Consistent with these findings, 
my data demonstrated that LPS increased the activation of MAPK, NFκB, and AP-1 in 
human MΦs, increasing their capacity to cause inflammation and insulin resistance in 
primary human adipocytes.    
Review of Literature 
 Recent attention has focused on the anti-inflammatory properties of bioactive food 
components.  Because fruits and fruit extracts are abundant in bioactive components such 
as polyphenols, they possess an immense potential to prevent the development of obesity-
related inflammation and insulin-resistance.  Several grape products have been shown to 
reduce markers of inflammation or oxidative stress associated with cardiovascular disease 
in vivo, ex vivo, and in vitro (reviewed in Perez-Jimenez et al. 2008 and Leifert et al. 
2008).  For example, consumption of red grape juice by hemodialysis patients, who suffer 
from hemodialysis-induced oxidative stress, reduced plasma levels of oxidize LDL and 
ex vivo neutrophil NAPDH oxidase activity (Castilla et al. 2008). Similarly, consumption 
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of red grape juice decreased markers of oxidative stress in healthy adults (O’Bryne et al. 
2002). Consumption of grape powder by adult women decreased the levels of plasma 
tumor necrosis factor (TNF)-α and urinary F2-iosoprostanes, markers of inflammation 
and oxidative stress, respectively (Zern et al. 2005). Similarly, adults consuming red wine 
had lower urinary levels of PGF-2α levels and higher plasma levels of polyphenols 
compared to those consuming white wine or no wine (controls) (Pignatelli et al. 2006).  
 Salt-sensitive, hypertensive Dahl rats supplemented with grape powder had decreased 
cardiac oxidative damage and plasma levels of interleukin (IL)-6 and TNFα compared to 
unsupplemented control rats (Seymour et al. 2008).  Zucker rats fed a high fat diet 
supplemented with grape seed procyanidins had lower plasma levels of C-reactive protein 
(CRP) and lower WAT mRNA levels of CRP, TNFα, and IL-6 compared to high fat fed 
control rats (Terra et al. 2009).  Apolipoprotein E deficient mice, who suffer from 
atherosclerosis and oxidative stress, supplemented with grape powder had a lower 
incidence of atherosclerotic plaque formation and decreased markers of oxidative stress 
compared to controls (Fuhrman et al. 2005). Furthermore, consumption of grape powder 
by apolipoprotein E deficient mice decreased the capacity of their peritoneal MΦs to 
oxidize LDL. Consistent with these data, grape seed proanthocyanidin supplementation to 
cholesterol-fed hamster’s decreased MΦ-mediated, aortic foam cell development by 50% 
compared to the unsupplemented controls (Vinson et al. 2002).   
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  In vitro, grape seed procyanidins decreased cholesterol and TG accumulation in MΦ-
derived foam cells (Terra et al. 2009) and modulated the inflammatory response in 
endotoxin-stimulated RAW264 MΦs by inhibiting NFκB (Terra et al. 2007).  In addition, 
human MΦ (THP-1 cell line) and adipocytes (SGBS cell line) treated with grape seed 
procyanidins had reduced expression of IL-1 and monocyte chemotactic protein (MCP)-1 
and decreased activation of NFκB following stimulation with LPS or TNFα, respectively 
(Chacón et al. 2009).  Moreover, oligomerized grape seed polyphenols have been shown 
to reduce NFκB transcriptional activity and activation of extracellular signal-related 
kinase (ERK) in a co-culture of adipocytes and MΦs (Sakurai et al. 2009). Consistent 
with these findings, my preliminary data show that GPE attenuates LPS-mediated 
inflammatory gene expression in MΦs, possibly by decreasing activation of JNK, p38, c-
Jun, Elk-1, or NFκB.   
 However, the ability of GPE to prevent inflammation in human MΦs and block 
inflammation and insulin resistance in human adipocytes treated with conditioned media 
(CM) from activated MΦs and its mechanism of action are unknown.  Thus, experiments 
described in the next chapter were designed to test the central hypothesis and carry out 
the specific aim of this project. 
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Fig 1.1. MФ recruitment into WAT. Weight gain results in hypertropic adipocytes 
that release chemokines such as monocyte chemoattractant protein (MCP-1) that recruit 
MФs into WAT.  Activated infiltrated MФs, in turn, release chemokines (IP-10, IL-8) 
and cytokines (TNFα, IL-6) amplifying the inflammatory response in WAT, leading to 
insulin resistance. 
 
 
 
 
 
 
 
8 
 
Fig 1.2. Proposed mechanism by which GPE prevents inflammatory gene 
expression in human MΦs.  GPE blocks LPS-mediated activation of c-Jun N-
terminal kinase (JNK), p38, NFκB, or activator protein AP-1 (i.e. c-Jun). 
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CHAPTER II 
 
POLYPHENOL-RICH GPE ATTENUATES INFLAMMATION IN HUMAN 
MACROPHAGES (MФ)S AND IN HUMAN ADIPOCYTES EXPOSED TO  
MФ-CONDITIONED MEDIA 
 
 
 
Abstract 
Obesity-associated inflammation is characterized by an increased abundance of 
MΦs in WAT, leading to the production of inflammatory cytokines, chemokines, and 
PGs that can cause insulin resistance. GPE is rich in phenolic phytochemicals that 
possess anti-oxidant and anti-inflammatory properties. Thus, I examined the ability of 
GPE to prevent LPS-mediated activation of MAPKs, NFκB, and AP-1, and induction of 
inflammatory genes in human MΦs.  In addition, I investigated the extent to which GPE 
pretreatment of MΦs prevented inflammation and insulin resistance in human adipocytes 
incubated with MΦ-conditioned media (MΦ-CM).  Pretreatment of MΦs with GPE 
attenuated LPS-induction of inflammatory cytokines such as TNFα, interleukin IL-6, and 
IL-1β, chemokines such as IL-8 and interferon (IFN)γ inducible protein (IP)-10, and a 
marker of PG production, cyclooxygenase (COX)-2. GPE also attenuated LPS activation 
of MAPKs, NFκB, and AP-1 (c-Jun) as evidenced by decreased 1) phosphorylation of 
JNK and p38, 2) degradation of IκBα and  activation of an NFκB reporter construct,  and 
3) phosphorylation of c-Jun and Elk-1. Using LPS-challenged MΦ-CM, GPE 
pretreatment attenuated MΦ-mediated inflammatory gene expression, activation of an 
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NFκB reporter, and suppression of insulin-stimulated glucose uptake in human 
adipocytes.  Collectively, these data demonstrate that GPE attenuates LPS-mediated 
inflammation in human MΦs, possibly by decreasing the activation of MAPK, NFκB, 
and AP-1, and that GPE decreases the capacity of LPS-stimulated MΦs to inflame 
adipocytes and cause insulin resistance.  
 
The incidence of obesity is increasing worldwide and due to its associated 
comorbidities, is becoming a major public health concern (reviewed in Tilg et al 2006 
and  Poirier et al. 2006). Obesity is considered a low-grade, chronic inflammatory disease 
characterized by macrophage (MΦ) infiltration to WAT (reviewed in Cottam et al. 2004 
and Trayhurn et al. 2004). Secretion of proinflammatory mediators from activated MΦs 
exacerbates WAT inflammation, thereby contributing to the pathogenesis of obesity-
related diseases such as atherosclerosis, type 2 diabetes, and hypertension (Laine et al. 
2007). Indeed, obese individuals present with increased serum and tissue levels of 
inflammatory markers such as TNFα, IL-6, and MCP-1 (Wellen et al. 2005, Fantuzzi et 
al. 2004). Notably, several studies reported that MΦs are the primary source for 
proinflammatory cytokine production in WAT and may be recruited to WAT via MCP-1 
(Fain et al. 2004, Clément et al. 2004, Curat et al. 2006, Kanda et al. 2006, Skurk et al. 
2005). Furthermore, numerous animal studies have demonstrated the importance of MΦs 
in inflammation-induced insulin resistance (Kanda et al. 2004, Lumeng et al. 2007, Arkan 
et al. 2005, Weisberg et al. 2005). 
Introduction 
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     High blood levels of LPS are indicative of metabolic endotoxemia (Cani et al. 2008), 
and activate immune cells, including MΦs. LPS activates toll-like receptors (TLR) and 
co-receptors (CD14, MD-2) on these cells, triggering an inflammatory signaling cascade 
involving MAPKs, NFκB, Elk-1, and AP-1. These activated proteins induce the 
transcription of many proinflammatory genes including cytokines, chemokines, and other 
immunomodulators that adversely affect WAT, triggering inflammation and insulin 
resistance. Notably, diet-induced obesity increases plasma levels of LPS in mice, which 
contributes to obesity, inflammation, and insulin resistance in these animals (Cani et al. 
2008).  Therefore, reducing chronic inflammatory cytokine production through inhibition 
of the MAPK and NFκB signaling pathways in MΦs may prevent obesity-associated 
inflammation and insulin resistance.  
 Recent attention has focused on the anti-inflammatory properties of bioactive food 
components.  Because fruits and fruit extracts are abundant in bioactive components such 
as polyphenols, they possess an immense potential to prevent the development of obesity-
related inflammation and insulin-resistance. Grapes are one of the most widely consumed 
fruits in the world (Sakurai et al. 2009). They contain high concentrations of polyphenols 
which have been shown in numerous in vivo and in vitro studies to exert anti-
inflammatory and anti-oxidant effects. For example, grape seed procyanidin modulated 
the inflammatory response in endotoxin-stimulated RAW264 MΦs by inhibiting NFκB 
(Terra et al. 2007).  In addition, oligomerized grape seed polyphenols have been shown to 
reduce NFκB transcriptional activity and activation of ERK in a co-culture of murine 
adipocytes and MΦs (Sakurai et al. 2009). However, the ability of GPE) to prevent 
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inflammation in human MΦs and block inflammation and insulin resistance in human 
adipocytes treated with MΦ-CM is unknown.  Furthermore, the potential anti-
inflammatory mechanisms of action of GPE are unknown.  
 In the present study, we hypothesized that GPE would prevent LPS-mediated 
activation of MAPK, NFκB, Elk-1 and AP-1, and subsequent induction of inflammatory 
genes in human MΦs.  Furthermore, we speculated that GPE would decrease 
inflammation and insulin resistance in primary cultures of human adipocytes incubated 
with LPS-challenged MΦ-CM.   
 
Materials 
Materials and Methods 
All cell culture-ware were purchased from Fisher Scientific (Norcross, GA). Fetal 
bovine serum (FBS) was purchased from Hyclone (Logan, UT).  RPMI 1640 was 
purchased from ATCC (Manassas,VA). LPS was purchased from Sigma-Aldrich (St. 
Louis, MO). Tri Reagent was purchased from Molecular Research Center (Cincinnati, 
OH). Gene-specific primers were purchased from Applied Biosystems (Foster City, CA). 
Polyclonal antibody for anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho 
(Thr180/Typ182) and total p38 antibodies were purchased from BD Bioscience 
Pharmingen (San Jose, CA). Anti-phospho (Thr183/Tyr185) and total c-jun NH2-terminal 
kinase (JNK), anti-phospho (Ser63) c-Jun and total c-Jun, anti-phospho (Ser383) Elk-1, 
and anti- IκBα antibodies were purchased from Cell Signaling Technologies (Beverly, 
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MA). Immunoblotting buffers and precast gels were purchased from Invitrogen 
(Carlsbad, CA). Western Lightning chemiluminescence substrate was purchased from 
Perkin Elmer Life Science (Boston, MA).  All other reagents and chemicals were 
purchased from Sigma-Aldrich unless otherwise stated. 
 
Culturing of human MΦs 
  Human U937 monocytes were purchased from ATCC (Manassas, VA). Cells 
were seeded in 35-mm dishes at 0.75 x 106 cells per 35 mm or 1.25  x 106 cells per 60 
mm dish and differentiated with 30 µg/L phorbol 12-myristate (PMA) for 24 h in RPMI 
1640 (containing 10% FBS, 60 UmL-1 penicillin, 60 U/L-1 streptomycin and 25 µgmL-1 
amphotericin B).  Media was then changed to PMA-free RPMI and 24 h later the 
experiments were initiated with the MΦ monolayers. Cultures were incubated at 37°C in 
a humidified O2:CO2 (95:5%) atmosphere.   
 
Culturing of human primary adipocytes 
 Abdominal WAT was obtained from non-diabetic Caucasian and African 
American females, between the ages of 20-50 years old with a body mass index (BMI) 
less than 32.0 kg (m2)-1 following abdominoplasty. Approval was obtained from the 
Institutional Review Board at the University of North Carolina at Greensboro and the 
Moses Cone Memorial Hospital in Greensboro, NC. Tissue was digested using 
collagenase and stromal vascular (SV) cells were isolated and cultured as previously 
described (Brown et al. 2004). MΦ-free cultures containing ~50% preadipocytes and 
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~50% adipocytes, based on visual observations and previous analyses (Chung et al. 
2006), were treated between day 6-12 of differentiation. Each experiment was repeated at 
least twice at different times using a mixture of cells from 2-3 subjects unless otherwise 
indicated. 
 
Source and preparation of GPE 
 Lyophilized grape powder, obtained from red, green, and blue-purple seeded and 
seedless California (CA) table grapes, was acquired from the California Table Grape 
Commission (CTGC). This grape powder has been reported to contain several types of 
polyphenols including anthocyanins, monomeric flavanols, flavonols, and stilbenes 
(Seymour et al. 2008). The powder was extracted to remove the sugars (90% w/w)  using 
a Diaion HP-20 anion resin column and eluted from the column using methanol, and 
subsequently lyophilized per a protocol provided by the CTGC. GPE was dissolved in 
dimethyl sulfoxide (DMSO) to make the concentration of 100 mgmL-1 as the stock 
solution and stored at -20oC. Stock concentrations were diluted immediately prior to use. 
 
Analysis of GPE polyphenols 
Several polyphenols in GPE were determined (Fig. 2.1) using reverse phase high-
performance liquid chromatography (HPLC) as previously described (Xie et al. 2007). 
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RNA isolation and real-time quantitative PCR (qPCR) 
Following treatment, cells were harvested and total RNA was isolated using Tri-
Reagent according to the manufacturer’s protocol. For real time qPCR, 2.0 µg total RNA 
was converted into first strand cDNA using Applied Biosystems High-Capacity cDNA 
Archive Kit. The qPCR was performed in an Applied Biosystems 7500 FAST Real Time 
PCR System using Taqman Gene Expression Assays. To account for possible variation 
related to cDNA input or the presence of PCR inhibitors, the endogenous reference gene 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was simultaneously quantified for 
each sample, and data were normalized accordingly. 
 
Analysis of secretion of IL-6 and interferon-γ inducible protein-10 (IP-10) through 
multiplex cytokine assay 
The concentrations of IL-6 and IP-10 were determined using the BioPlex® 
Suspension Array System from Bio-Rad (Hercules, CA) following the manufacturer’s 
protocol.   
 
SDS-page western immunoblotting analysis 
After experimental treatments, the medium was removed quickly, and the 
monolayers were washed gently once with ice-cold HBSS.  RIPA lysis buffer was then 
added containing Tris HCL (pH 7.5), 1% Nonidet P-40, 0.25% sodium deoxycholate, and 
1 mM EDTA with protease and phosphatase inhibitors.  Monolayers were immediately 
scraped, transferred to prechilled microfuge tubes, and triturated to break up cells. Cell 
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lysates were then sonicated three times for 5 s.  Cell debris was pelleted by centrifugation 
at 12,000 rpm for 20 min at 4 °C, and the resulting supernatant was collected for analysis. 
The protein concentration of each sample was determined using a BCA assay. SDS-
PAGE and transfer of protein to polyvinylidene difluoride membranes were carried out 
on the same day as the protein harvest to prevent freeze-thaw degradation of 
phosphoproteins.  After transfer, membranes were blocked in Tris-buffered saline (TBS), 
supplemented with 0.1% Tween 20 (TBS-T) and 5% nonfat dried milk for 1 h at room 
temperature. The membranes were washed twice with TBS-T and incubated in TBS-T 
supplemented with 5% BSA and the following primary antibodies overnight at 4 °C: 
rabbit polyclonal Anti-phospho (Thr183/Tyr185) and total c-jun NH2-terminal kinase 
(JNK), anti-phospho (Ser63) c-Jun and total c-Jun, anti-phospho (Ser383) Elk-1, and anti- 
IκBα antibodies all from Cell Signaling Technologies, mouse monoclonal anti-phospho 
(Thr180/Tyr182) and total p38 from BD Transduction Laboratories, and  goat polyclonal 
antibody for anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was purchased 
from Santa Cruz Biotechnology . The next morning, primary antibody was washed three 
times for 5 min with TBS-T, and the membranes were immediately incubated with the 
appropriate horseradish peroxidase-conjugated secondary antibodies for 1 h. After three 
washes with TBS-T, chemiluminescence was initiated by the addition of Western 
Lightning Plus (Perkin Elmer Life Sciences) and subsequent exposure to x-ray film.  
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Transient transfections of MΦs 
 Differentiated U937 cells were transiently transfected with the NFκB responsive 
luciferase (luc) reporter construct pNFκB luc (Strategene, La Jolla, CA) using the Amaxa 
Nucleofector.  1.25 x 106 cells from a 60 mm plate were collected by scraping with 10 
mmol/L EDTA and resuspended in 100 μL of nucleofector solution (Amaxa) and mixed 
with 2 μg of pNFκB luc and 25 ng pRL-CMV for each sample. Electroporation was 
performed using the W-005 nucleofector program (Amaxa). Cells were replated in 96-
well plates after 10 min recovery in RPMI media. Following 24 h, transfected cells were 
pretreated with 10 µgmL-1  GPE for 1 h and treated with 100 ngmL-1 LPS for 8 h. This 8 
h treatment with LPS was chosen based on the results of a pilot time course study (data 
not shown). Firefly luciferase activity was measured using the Dual-Glo luciferase kit 
and normalized to Renilla luciferase activity from the cotransfected control pRL-CMV 
vector. All luciferase data are presented as a ratio of firefly luciferase to Renilla 
luciferase activity.     
 
MΦ CM experiments in primary human adipocytes 
CM was collected from differentiated U937 cultures pretreated for 1 h with or 
without 10, 30, 60, or 100 µgmL-1 GPE followed by treatment for 3 h with 100 ngmL-1 
LPS. MΦ-CM obtained from each experiment was pooled and stored at -80°C until used. 
Distinct pools were used for each experiment. For RNA isolation and qPCR experiments, 
primary human adipocytes were seeded in 35-mm dishes at 0.5 x 106 per dish and 
allowed to differentiate for 6 d. On day 6, media was changed and cells were incubated in 
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1 mL of AM-1.  Twenty-four hours later, the following were added to the cultures 1) 
fresh adipocyte medium (AM-1), 2) fresh RPMI, 3) LPS challenged MΦ-CM, or 4) LPS-
challenged MΦ-CM pretreated with GPE. The amount and duration of MΦ-CM 
treatment varied depending on the outcome measured. 
 
Transient transfections of primary human adipocytes 
 Primary human adipocytes were transiently transfected with the NFκB 
responsive luciferase (luc) reporter construct pNFκB luc (Strategene) using the Amaxa 
Nucleofector. On day 6 of differentiation, 1.2 x 106 cells from a 60 mm plate were 
trypsinized and resuspended in 100 μL of nucleofector solution (Amaxa) and mixed with 
1 μg of pNFκB luc and 25 ng pRL-CMV for each sample. Electroporation was performed 
using the V-33 nucleofector program (Amaxa). Cells were replated in 96-well plates after 
10 min recovery in calcium-free RPMI media. Following 24 h, transfected cells were 
treated for 24 h with GPE- or LPS- MΦ-CM as described above. This 24 h treatment with 
LPS- MΦ-CM was chosen based on the results of a pilot time course study (data not 
shown).  Firefly and Renilla luciferase activity were measured as described above for the 
transfected MΦs.    
 
2-[3H]deoxy-glucose (2-DOG) uptake 
Primary human adipocytes were incubated with low glucose (5 mmol/L) and 
insulin (20 pmol/L)-containing media for 24 h. Cultures were then treated with LPS 
challenged MΦ-CM or CM from LPS-challenged MΦ pretreated with GPE for 24 h. 
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Basal and insulin-stimulated 2-DOG were measured as described previously (Brown et 
al. 2004).  
 
Statistical analysis  
Statistical analyses were performed for data in Figure 2a by testing the main 
effects of GPE dose (- or +) and LPS (- or +) and their interaction (GPE x LPS) using 
two-way ANOVA (JMP Version 6.03, SAS Institute, Cary, NC). A one-way ANOVA 
was conducted for data in Figures 2b, 4b, and 5. Student’s t tests were used to compute 
individual pairwise comparisons of least square means, P<0.05. Data are expressed as 
means ± S.E.M. 
 
Polyphenol composition of GPE  
Results 
Analysis of our GPE by reverse phase HPLC by Dr. Wei Jia at the UNCG Center 
for Research Excellence in Bioactive Food Components, Kannapolis, NC revealed a high 
concentration of the polyphenol quercetin-3-glucoside (Q3G) (Fig. 2.1).  Other 
polyphenols included catechins (7.3%), epicatechins (1.9%), gallic acid (1.4%), rutin 
(1.2%), and resveratrol (0.53%). 
 
GPE decreases LPS-induced inflammatory gene expression 
  To determine the extent to which GPE attenuated markers of inflammation, 
differentiated U937 cells were pretreated for 1 h with GPE (0, 10, 30, or 100 µgmL-1 ) 
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and stimulated with 100 ngmL-1 LPS for 3 h. LPS treatment markedly increased the 
expression of IL-6, IL-8, IL-1β, TNFα, and GPE decreased the induction of these genes 
in a dose-dependent manner (Fig. 2.2a). LPS-induced IP-10 was blocked by 10 µgmL-1   
GPE, and COX-2 induction was attenuated to the same extent with 10 and 30 µgmL-1   
GPE, and blocked by 100 µgmL-1 GPE (Fig. 2.2a). In the absence of LPS, GPE alone did 
not affect inflammatory gene expression (Fig. 2.2a).  Because LPS-mediated induction of 
IP-10 and IL-6 was decreased to the greatest extent by GPE, we measured their secretion 
in the CM. IL-6 secretion was robustly increased by LPS, whereas IP-10 was only 
slightly increased (Fig. 2.2b). LPS-mediated IL-6 secretion was modestly decreased by 
30 µgmL-1 GPE, whereas IP-10 secretion was blocked by GPE. These differences may be 
due to the level of secretion induced by LPS. No visual cytotoxic effects of GPE were 
observed (e.g., no floating cells or changes in cell morphology). 
GPE decreases LPS-mediated activation of MAPK 
Given the important role of MAPK in activating transcription factors that induce 
inflammatory gene expression, we examined the effects of GPE on the phosphorylation 
of MAPK in MΦs. Differentiated U937 cells were pretreated for 1 h with GPE (0, 30, 60, 
or 100 µgmL-1) and stimulated with 100 ngmL-1 LPS for 30 min. GPE attenuated LPS 
phosphorylation of JNK and p38 in a dose dependent manner (Fig. 2.3).  In the absence 
of LPS, GPE alone did not affect phosphorylation of JNK or p38. Phosphorylation levels 
of ERK were also measured, but GPE did not attenuate LPS phosphorylation of ERK 
(data not shown). 
 
21 
 
GPE decreases LPS-mediated NFκB, AP-1, and Elk-1 activation 
 To determine the extent to which GPE prevented LPS activation of the 
inflammatory transcription factors NFκB, AP-1, and Elk-1, IκBα degradation, c-Jun, and 
Elk-1 phosphorylation and NFκB reporter activity were determined in differentiated 
U937 cells. Pretreatment of MΦs with 100 µgmL-1  GPE attenuated LPS-mediated IκBα 
degradation (Fig. 2.4a). GPE decreased LPS-stimulated phosphorylation of c-Jun in a 
dose dependent manner (Fig. 2.4a). Pretreatment of MΦs with 60 µgmL-1  and 100 
µgmL-1  GPE decreased LPS-stimulated Elk-1 phosphorylation.  In the absence of LPS, 
GPE had no effect on IκBα degradation, but slightly increased phosphorylation of c-Jun 
and Elk-1 (Fig. 2.4a). Finally, 10 µgmL-1 GPE and 0.1 µM Rosiglitazone (i.e., BRL, a 
positive control) blocked NFκB reporter activation by LPS (Fig. 2.4b). 
 
GPE pretreatment of MΦs decreases MΦ-CM-mediated inflammation and insulin 
resistance in human adipocytes 
Several studies have reported cross-talk between murine MΦs and adipocytes; 
i.e., activated MΦs can inflame adipocytes and vice-versa (Suganami et al. 2005). 
Therefore, we hypothesized that GPE pretreatment of LPS-treated MΦs would prevent 
MΦ-CM-mediated inflammation and insulin resistance in human adipocytes. Consistent 
with our hypothesis, 30  µgmL-1  GPE pretreatment decreased MΦ-mediated 1) induction 
of inflammatory gene expression (Fig. 2.5a), 2) activation of an NFκB reporter (Fig. 
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2.5b), and 3) impairment of insulin-stimulated glucose uptake (Fig. 2.5c) in human 
adipocytes.   
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Figure 2.1 Polyphenol composition of GPE.  Reverse phase HPLC of GPE indicates 
quercetin-3-glucoside is a major component of GPE (conducted by Dr. Jia).   
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Figure 2.2 GPE blocks LPS-mediated inflammatory gene expression and protein 
secretion in human MΦs.   (a) Differentiated U937 cultures were pretreated with 0, 10, 
30, or 100 µgmL-1 GPE for 1 h and then treated with 100 ngmL-1 LPS for 3 h.  The 
mRNA levels were measured by qPCR. Data are representative of three independent 
experiments. Means (± SE; n=3) without a common letter differ (P<0.05). (b) Cultures 
were pretreated + 30 µgmL-1  GPE (G) for 1 h and then treated  + 100 ngmL-1  LPS (L) 
for 12 h. Levels of IP-10 and IL-6 in CM were measured using BioRad’s Multi-Plex 
System. Means (± SE; n=6) without a common letter differ, P<0.05.  Data are 
representative of two independent experiments.   
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Figure 2.3 GPE attenuates LPS-mediated MAPK activation in MΦs. Differentiated 
U937 cells were pretreated  0, 30, 60, or 100 µgmL-1 GPE for 1 h and then treated with 
100 ngmL-1 LPS for 30 min. Proteins were immuno-blotted and probed with phospho-(P) 
or non-P specific antibodies for JNK and p38. Data are representative at least three 
independent experiments. 
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Figure 2.4 GPE attenuates LPS-mediated NFκB, c-Jun, and Elk-1 activation in 
MΦs. (a) Differentiated U937 cells were pretreated  0, 30, 60, or 100 µgmL-1  GPE for 1 
h and then treated with 100 ngmL-1  LPS for 30 min.  Proteins were immuno-blotted and 
probed with phospho-(P) or non-P specific antibodies for, IκBα, c-Jun, Elk-1, or 
GAPDH. Data represent at least two independent experiments. (b) Cultures were 
pretreated with 10 µgmL-1  GPE or 0.1 µM BRL (Rosiglitazone) for 1 h and then treated 
with 10 ngmL-1  LPS for 8 h. NFκB reporter activity was measured using a luciferase 
assay. NFκB levels for the LPS+BRL treatment were non-detectable (ND). Means (± SE; 
n=5-6) without a common letter differ, P<0.05. Data represent three independent 
experiments.   
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Figure 2.5 GPE decreases the inflammatory and insulin desensitizing capacity of 
MΦ-CM in human adipocytes.  Differentiated U937 cells were pretreated with 0, 10, 
30, 60, or 100 µgmL-1  GPE for 1 h and then treated with 100 ngmL-1  LPS for 3 h.  MΦ-
CM was collected and used to treat adipocytes for 3-24 h at a 1:1 ratio in AM-1. (a) 
Adipocytes were treated with MΦ-CM for 3 h and then harvested for qPCR analysis 
(n=3). (b) Adipocytes transfected with an NFκB reporter were treated with MΦ-CM for 
24 h and then were assayed for luciferase activity (n=4-6). (c) Adipocytes were treated 
with LPS-challenged MΦ-CM (L) or LPS-challenged MΦ-CM pretreated with GPE 
(L+G) for 24 h and 2-DOG uptake was measured (n=3-6). Means (± S.E.M.) without a 
common letter differ, P<0.05.  Data in (a)-(c) are representative of at least two 
independent experiments.   
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In this study, we demonstrated that GPE attenuated LPS-induced expression of 
IL-6, IL-8, IL-1β, IP-10, TNFα, and COX2 and subsequent secretion of IL-6 and IP-10 in 
human MΦs.  GPE also attenuated LPS activation of JNK and p38, and the transcription 
factors NFκB, AP-1 (i.e., c-Jun), and Elk-1. Furthermore, we showed that GPE decreased 
inflammatory gene expression (i.e., IL-6, IL-8, IL-1β, and MCP-1) and NFκB activity, 
and improved insulin-stimulated glucose uptake in human adipocytes treated with LPS-
challenged MΦ-CM. Taken together, these findings demonstrate that GPE inhibits LPS-
mediated activation of inflammatory MAPK and transcription factors that induce 
inflammatory gene expression and protein secretion in cultures of human MΦs. This 
suppression of inflammatory protein secretion by GPE likely contributed to the decreased 
the ability of CM from LPS-stimulated MΦs to cause inflammation and insulin resistance 
in human adipocytes.  Based on these data, we propose that GPE directly attenuates LPS 
activation of MAPK, NFκB, and AP-1 in MΦs, thereby preventing the induction and 
secretion of inflammatory cytokines (e.g., IL-6) and chemokines (i.e., IP-10). This 
decreased production of inflammatory mediators prevents MΦs from causing 
inflammation and insulin resistance by attenuating the activation of NFκB in adipocytes.   
Discussion 
 Consistent with these data, increased levels of LPS have been found in the plasma of 
high-fat fed obese mice (Cani et al. 2009), which contributes to inflammation and insulin 
resistance. LPS activates MAPK, NFκB, and AP-1, increasing the release of 
inflammatory cytokines and chemokines (Terra et al. 2007, Jang et al. 2008, Chen et al. 
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2007). In obesity, the increased production of these inflammatory mediators originates 
mainly from infiltrating MΦs in WAT (Xu et al. 2003, Weisberg et al. 2003). MΦ-
secreted factors have been shown to increase inflammation and decrease insulin-
stimulated glucose uptake in adipocytes (Lumeng et al. 2007, Permana et al. 2006).  
Consistent with these findings, we found that LPS increased the activation of MAPK, 
NFκB, and AP-1 in human MΦs, increasing their capacity to cause inflammation and 
insulin resistance in primary human adipocytes.    
 Several grape products have been shown to reduce markers of inflammation or 
oxidative stress associated with cardiovascular disease in vivo, ex vivo, and in vitro 
(reviewed in Perez-Jimenez et al. 2008 and Leifert et al. 2008).  For example, 
consumption of red grape juice by hemodialysis patients, who suffer from hemodialysis-
induced oxidative stress, reduced plasma levels of oxidize LDL and ex vivo neutrophil 
NAPDH oxidase activity (Castilla et al. 2008). Similarly, consumption of red grape juice 
decreased markers of oxidative stress in healthy adults (O’Bryne et al. 2002). 
Consumption of grape powder by adult women decreased the levels of plasma TNFα and 
urinary F2-iosoprostanes, markers of inflammation and oxidative stress, respectively 
(Zern et al. 2005). Similarly, adults consuming red wine had lower urinary levels of PGF-
2α levels and higher plasma levels of polyphenols compared to those consuming white 
wine or no wine (controls) (Pignatelli et al. 2006). 
 Salt-sensitive, hypertensive Dahl rats supplemented with grape powder had decreased 
cardiac oxidative damage and plasma levels of IL-6 and TNFα compared to 
unsupplemented control rats (Seymour et al. 2008).  Zucker rats fed a high fat diet 
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supplemented with grape seed procyanidins had lower plasma levels of C-reactive protein 
(CRP) and lower WAT mRNA levels of CRP, TNFα, and IL-6 compared to high fat fed 
control rats (Terra et al. 2009).  Apolipoprotein E deficient mice, who suffer from 
atherosclerosis and oxidative stress, supplemented with grape powder had a lower 
incidence of atherosclerotic plaque formation and decreased markers of oxidative stress 
compared to controls (Zern et al. 2005). Furthermore, consumption of grape powder by 
apolipoprotein E deficient mice decreased the capacity of their peritoneal MΦs to oxidize 
LDL. Consistent with these data, grape seed proanthocyanidin supplementation to 
cholesterol-fed hamsters decreased MΦ-mediated, aortic foam cell development by 50% 
compared to the unsupplemented controls (Vinson et al. 2002).  
  In vitro, grape seed procyanidins decreased cholesterol and TG accumulation in MΦ-
derived foam cells (Terra et al. 2009).  In addition, human MΦ (THP-1 cell line) and 
adipocytes (SGBS cell line) treated with grape seed procyanidins had reduced expression 
of IL-1 and MCP-1 and decreased activation of NFκB following stimulation with LPS or 
TNFα, respectively (Chacón et al. 2009). Consistent with these findings, our data show 
that GPE attenuates LPS-mediated inflammatory gene expression in MΦs, possibly by 
decreasing activation of JNK, p38, c-Jun, Elk-1, or NFκB.  
 Because grapes contain a wide array of phytochemicals, the specific bioactive 
components responsible for the anti-inflammatory properties of grapes or GPE remain to 
be elucidated. Two promising candidates in grapes are resveratrol and quercetin which, 
based on our reverse phase HPLC analysis, were found to be present in our GPE.  For 
example, resveratrol attenuated the phagocytosis of bacteria by MΦs via decreased NFκB 
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activation (Iyori et al. 2009) and suppressed monocyte adhesion to human umbilical vein 
endothelial cells (Moon et al. 2006).  Furthermore, quercetin reduced the levels of 
inflammatory markers in LPS treated MΦ U937 cells (Okoko et al. 2009) and suppressed 
the degradation of IκBα and the phosphorylation of p38 and Akt in LPS-stimulated bone 
marrow-derived MΦs (Kaneko et al. 2008).  
 One potential mechanism by which GPE may block inflammation is by increasing 
peroxisome proliferator-activated receptor (PPAR)-γ expression or activation.  PPAR-γ 
has been described as a general negative regulator of MΦ activation and has been 
implicated in muscle and hepatic insulin sensitivity and in inflammation.  PPAR-γ 
agonists such as TZDs reduce inflammatory gene expression in MΦ (Necela et al. 2008) 
and when administered before the onset of inflammation, TZDs exhibit beneficial effects 
on experimental models of inflammation such as colitis (Su et al. 1999, Desreumaux et 
al. 2001, Saubermann et al. 2002, Katayama et al. 2003, Lytle et al. 2005, Schaefer et al. 
2005) , atherosclerosis (Nagy et al. 1998, Tontonoz et al. 1998, Li et al. 2000, Zhang et 
al. 2004), asthma (Hammad et al. 2004, Woerly et al. 2003, Trifillieff et al. 2003), 
psoriasis (Demerjiann et al. 2006), myocarditis (Hasegawa et al. 2005, Yuan et al. 2004) 
and allergic encephalomyelitis (Natarajan et al. 2002, Diab et al. 2002).  In addition, 
anthocyanins such as Cyanidin-3-O-β-glucoside have also been shown to enhance the 
expression and transcriptional activities of PPAR-γ in MΦ (Wang et al. 2008, Xia et al. 
2005).  The underlying mechanisms are not fully elucidated but it has been suggested that 
PPAR-γ activation exerts its anti-inflammatory function by trans-repressing the NFĸB 
and MAPK pathways (Szanto et al. 2008, Varga et al. 2008). Thus, GPE may be 
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attenuating LPS-mediated activation of NFĸB and MAPKs by acting as a PPAR-γ 
agonist.  Studies are underway in our laboratory to determine the extent to which the 
phytochemicals resveratrol and quercetin contribute to the anti-inflammatory and insulin-
sensitizing properties of GPE. Other polyphenols in GPE that may also decrease 
inflammation include anthocyanins and flavanols (Seymour et al. 2008). 
 Collectively, these data demonstrate that GPE attenuates LPS-mediated inflammatory 
gene expression and protein secretion in human MΦs, possibly by suppressing the 
activation of JNK, p38, c-Jun, Elk-1, or NFκB. Furthermore, GPE decreased the 
inflammatory capacity of LPS-challenged MΦ-CM, attenuating its ability to cause 
inflammation and insulin resistance in primary human adipocytes. Future in vivo studies 
are needed to recapitulate these in vitro findings, and determine the bioactive 
component(s) in GPE. 
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CHAPTER III 
 
EPILOGUE 
 
 
 Obesity produces a state of chronic, low-grade inflammation that contributes to the 
pathogenesis of numerous diseases including type 2 diabetes, atherosclerosis, and 
hypertension.  Although the exact cellular origin of this inflammatory response remains 
to be fully elucidated, recent attention has focused on the role infiltrating MΦs play in 
WAT inflammation.  Preventing this inflammatory response in MΦs with polyphenol-
rich foods like grapes could help prevent or delay the development of obesity-related 
diseases.  Indeed, consumption of polyphenol-rich foods like grapes or their by-products 
has been reported to prevent inflammatory-related diseases.  Therefore, this project 
examined the extent to which GPE attenuated inflammatory markers in human MΦs and 
the underlying mechanisms behind this effect. 
Based on my findings, I propose that GPE attenuates LPS activation of MAPK, 
NFκB, and AP-1 in MΦs, thereby preventing the induction and secretion of inflammatory 
mediators.  This decreases the ability of MΦs to cause inflammation and insulin 
resistance in adipocytes.  These results have led to the development of the following new 
questions 1) What are the bioactive components in GPE contributing to anti-
inflammatory effects? 2) What effects do GPE or its bioactive components have on 
PPARγ in human MΦs, and 3) Can these results be recapitulated in vivo?     
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Q1. What are the bioactive components in GPE contributing to its anti-inflammatory 
effects? 
Two polyphenols that have been shown to possess anti-inflammatory properties 
and are present in GPE include QUE (i.e., quercetin-3-glucoside (Q3G)) and RSV.  
Because QUE was found to be more abundant than RSV, I investigated the ability of 
QUE to attenuate LPS-mediated inflammatory gene expression in human MΦs.  I used 
QUE instead of Q3G because they both equally decreased IL-6 and IP-10 gene 
expression in LPS-treated MΦs.  Thus, I repeated the studies conducted in Chapter II 
with QUE instead of GPE.  Consistent with GPE, QUE decreased LPS induction of IL-6 
and IP-10 gene expression and protein secretion into CM (Fig. 3.1a and 3.1b).  However, 
QUE did not attenuate LPS-induced IL-1β, IL-8, COX-2, or TNFα gene expression (data 
not shown).  Furthermore, QUE did not decrease LPS activation of MAPK, NFκB, or 
AP-1 in MΦs, nor did it decrease the capacity of LPS-challenged MΦ-CM from causing 
inflammation and insulin resistance in human adipocytes (data not shown).  Interestingly, 
in the absence of LPS, QUE attenuated IL-6, IP-10, TNFα, IL-8, IL-1β, and COX-2 gene 
expression (Fig. 3.2).  QUE also prevented IκBα degradation and decreased JNK and 
cJun phosphorylation in the absence of LPS (Fig. 3.3).  In addition, QUE pretreatment 
prevented MΦ-mediated insulin resistance in human adipocytes (Fig. 3.4).  Studies are 
underway to determine if QUE pretreatment prevents inflammatory gene expression in 
adipocytes challenged with MΦ-CM.  
Suprisingly, my recent preliminary data (n=2) shows that QUE and Q3G were not 
detectable in human MΦs exposed to GPE for 3-24 h.  However, ng levels QUE (0.1 and 
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0.2 ng) and Q3G (0.03 and 0.01 ng) were detectable in MΦs exposed to 30 uM QUE or 
60 uM Q3G for 8 or 24 h, respectively.  These analyses were performed by Dr. Jia using 
HPLC/MS.  The extent to which QUE or Q3G in GPE may have been metabolized into 
other metabolites is unknown, as we did not measure the disappearance of QUE or Q3G 
from the media of cells over time. Notably, 3.5 ng, 3.8 ng, and 4.6 ng of trans-RSV were 
detected in cells exposed to GPE for 3, 8, and 24 h, respectively.  However, these data do 
not mean that RSV is a more bioactive component than QUE from GPE, because the 
QUE could be rapidly interacting with cellular targets, thereby being transformed into 
other types of QUE metabolites or species.  These studies need to be repeated to confirm 
these results. 
 
Q2. What effects do GPE or its bioactive components have on PPARγ in human MΦs? 
One alternate mechanism by which GPE or its bioactive compounds decrease 
inflammation is by increasing  PPARγ activity, which has been reported to antagonize 
NFκB and AP-1 (Ricotte et al 2007, Straus et al 2007, Ghisletti et al 2007).  Based on my 
preliminary data showing LPS decreased PPARγ mRNA in MΦs, I would expect LPS to 
decrease PPARγ protein levels and activity as well.  Thus, I will examine the effects of 
GPE and its bioactive compounds on PPARγ expression and activity in LPS-treated 
MΦs.  I have conducted transient transfections studies in MΦs with a PPRE reporter 
construct; however I had problems getting the reporter transfected into the MΦs.  
Therefore, an alternate approach would be to use an electrophoretic mobility shift assay 
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(EMSA) to examine the extent to which LPS decreases PPARγ activity and whether GPE 
attenuates this effect. 
Q3. Can these results be recapitulated in vivo? 
Studies are underway in our research group to determine the extent to which 
grape powder (GP) polyphenols are absorbed in normal mice and prevent inflammation 
and insulin resistance in high fat (HF)-fed obese mice.  To examine the absorption of GP 
polyphenols, mice will be gavaged with GP and their blood will then be analyzed for GP 
polyphenols and their metabolites using ultra-performance liquid chromatography-
quadrupole time-of-flight mass spectrophotometry (UPLC-QTOFMS).  The effects of GP 
polyphenols on inflammation and insulin resistance in HF-fed obese mice will be 
examined by feeding obese mice a HF diet containing GP for 16 wks.  Blood will be 
taken at different times during this period to assess fasting glucose and insulin levels.  At 
the end of this study, mice will be euthanized and serum levels of inflammatory markers 
(IL-6, IL-8, MCP-1, IL-1β, TNFα, free fatty acids) and proteins associated with insulin 
resistance (i.e, decreased adiponectin) will be measured.  In addition, epididymal fat pads 
will be analyzed for mRNA markers of MΦ recruitment, inflammation, and insulin 
resistance.  From these studies, I hypothesize that several polyphenols detected in our GP 
extract (e.g, QUE, RSV) will indeed be detectable in the blood of mice.  Furthermore, I 
hypothesize that GP will reduce inflammatory gene expression and MΦ recruitment into 
WAT and improve insulin sensitivity in WAT. 
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In conclusion, the experiments discussed in this section would help to identify 
which polyphenols in GPE are absorbed and metabolized.  Studies will then be conducted 
to determine if these candidate polyphenols possess anti-inflammatory properties and if 
so, the mechanisms behind these effects can be elucidated through further in vitro studies.  
Most likely, we will find a number of polyphenols in GPE that have additive or 
synergestic effects in decreasing chronic, low grade inflammation.  
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Figure 3.1 QUE blocks LPS-mediated IP-10 and IL-6 gene expression and protein 
secretion in human MΦs.   (a) Differentiated U937 cultures were pretreated with 0, 3, 
10, or 30 µM QUE for 1 h and then treated with 100 ngmL-1  LPS for 3 h.  The mRNA 
levels were measured by qPCR. Data are representative of three independent 
experiments. Means (± SE; n=3) without a common letter differ (P<0.05). (b) Cultures 
were pretreated + 30 µM QUE (Q) for 1 h and then treated  + 100 ngmL-1  LPS (L) for 12 
h. Levels of IP-10 and IL-6 in CM were measured using BioRad’s Multi-Plex System. 
Means (± SE; n=6) without a common letter differ, P<0.05.  Data are representative of 
two independent experiments.   
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Figure 3.2 QUE attenuates inflammatory gene expression in human MΦs.  
Differentiated U937 cultures were treated with 0, 3, 10, or 30 µM QUE (Q) for 4 h.  The 
mRNA levels were measured by qPCR. Data are representative of three independent 
experiments. Means (± SE; n=3) without a common letter differ (P<0.05) 
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Figure 3.3 QUE attenuates IκBα degradation and JNK and cJun phosphorylation. 
Differentiated U937 cells were treated with 0, 3, 10, or 30 µM QUE.  Proteins were 
immuno-blotted and probed with phospho-(P) or non-P specific antibodies for, IκBα, c-
Jun, JNK, or GAPDH. Data are representative of two independent experiments. 
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Figure 3.4 QUE decreases the insulin desensitizing capacity of MΦ-CM in human 
adipocytes.  Differentiated U937 cells were treated with 0 (NT), 3, 10, 30 µM QUE for 5 
h and MΦ-CM was collected and used to treat adipocytes for 24 h at a 1:1 ratio in AM-1.  
2-DOG uptake was measured (n=4). Means (± SE; n=4) without a common letter differ, 
P<0.05.  Data are representative of one experiment.   
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